ML20150E450
| ML20150E450 | |
| Person / Time | |
|---|---|
| Issue date: | 02/11/1988 |
| From: | Rich Smith NRC OFFICE OF THE GENERAL COUNSEL (OGC) |
| To: | Mcelroy N NRC OFFICE OF NUCLEAR MATERIAL SAFETY & SAFEGUARDS (NMSS) |
| Shared Package | |
| ML20150E436 | List: |
| References | |
| FRN-53FR21627, RULE-PR-35 AC69-2-5, NUDOCS 8807150147 | |
| Download: ML20150E450 (4) | |
Text
i kM4 PDA
.)
j i
.?
ji' FEB 11 1988 i
NOTE TO:
Norm McElroy IMAB, NMSS FROM:
Ron Smith OCC
SUBJECT:
FEDERAL REGISTER NOTICE DIAGNOSTIC MISADMINISTRATION REPORT FORM As requested by you on Februarv 5, 1988, I have reviewed the proposed Federal Register notice concerning the above subject and find no legal objection to the substance of the final rule.
However, I would note some deficiencies in form as follows:
1.
As you intend to make the rule immediately effective upon publication and without public comment, a justification for that action is required.
See section 5.9(f),
NUREG/BR-0053, Rev.
1, November
- 1987, Regulations Handbook.
However, none of the examples provided therein appear to apply to this situation and the comment in your final rule on this issue does not appear to be appropriate.
Therefore, it is suggested that the following statement be 8ncluded in the Supplementary Section:
"This amendment is a minor administrative change to an existing final rule.
It merely adds the form number for an NRC form to the ccdUled rule.
The number had been omitted because OMB had not completed its review.
Based on this, good cause exists to find that the notice and public procedure provisions of the Administrative Procedure Act are unnecessary pursuant to the exemption provision found in 5 U.S.C. 553(b)(B). Therefore, the amendment is effective upon publicatica in the Federal Register."
2.
Within the categorical exclusion for an environmental statement, the reference to paragraph (c)(14) is unnecessary and should be deleted.
The words "for this final rule" should be added at the end of the statement.
3.
The Regulatory Analysis, Regulatory Flexibility Act, and Backfit Analysis statements have not been included as required by the Regulations Handbook.
(However, I can see where they don't necessarily appear to be appropriate.
You may wish to discuss these matters,with Rules and Records Division to see if there is a compromise or exception option available under this circumstance.)
(
8607150147 880629 l
PDR PR l
35 S3FR21627 PDR
}
kM-A.
- PD P, 4.
.There is a typographical error in the List of Subjects-section in that "Health devices" should read "Health facilities."
5.
The words of issuance-under the section Regulatory Text are not in conformance with section. 5.25 of the Regulations Handbook.
6.
The Authority citation must include the whole authority citation as it now reads, i.e., the sections issued under authority of 9 223, AEA.
Cw 0 on Smith 4
AUA4 POR N
poR3 en U S. NUCLE AM MGULATO4Y COMMIS$10N u
apure vo uw OWs 10 CF2 e:3 31 3150 0140 twees 5 31 E4 OlAGNOSTIC MISADMINISTRATION REPORT IN I) UCEN8Et Naut liN2n LICENSE NuwstR 1 I l-l l i I l l-l l iN3) CIT y INelSTAft tNSI EVENT OA 's tN61 R E POR T 0 A T E MONIM OAY VEAR MONTM OAV VtAR l l I
l f
f l
(N717YPt 0F uiSADMbP $T R A fl0N IN43 OIO TME w&ADMINeSTR ATION INv0Lvt AN IN9s NVuetR O8 PA f stNTS WMO RtClivEO ISOTOPtOFIOctNE A Wi$ ADMtNISTR ATiON UNDER TMis RE OR T 1011 WRONG 102 DOSAGE DipFERING R A 0iOPM A R MAC t W..C h l F AQM P45$CRiggO gy $Qg IO3t wAONG P ATIEN s l 104p wm0NG ROUTir l1999)YE1 l l (11tlNO IN10) IN T E Not 0 IN10AliNitNCEO IN113 GIVEN CMt CAL C",'O"h '
57VOY MILLicuRits' ISOTOPE 1061 NO CLahiCAL PROCEDUR E toel ULTRA 50uNo stuoY WILUCUPIES ISOTOPS sivoy p0 w
~
lo6) NUCLEAR ME0tCiNa
~
- 006 CT 87VOY
$Tuov scomeme Oto W h
g39, gy,t STVOY
'07) X M A Y S TVOY lillCTHER-fM12) PRICIPITATOR
( ) }gg[f/df$)fff)- M 176) MOT LAB TECHNOLOGIST 171) Rif ERRfNQ PHYSICI AN t r2) wARO NuRat arrl auAciNo fsCHNotooisY (73) WARD CLERK t7t) CUNIC R(CEPfl0NilT (74) NUC'.E AR PMARWACY (791 $CM400UNO TECHNOLOGisf NAW4 07 NUCLEAR MARMACT l CITY l$TAft gggg paygggy 1811OTHER tN131 ERROM MOT LAS RfFERRAL A DMINISTR AflON OTHER f
I l11) Me5LAttLEO A SYRINGE (Ill SELECTto WRONG vl AL f4 uisuNOERsT000 t301 SELECTto WRONG l 440) Spee#
WHEN DR Awi% DOSAGE RE F tRRING PHY$1CJ AN $
P A TitN T (12) WisLA8ELEO A vl AL RE0utti OR vial SMitLO (141 00sf SR A TM (31)
ERto A T1 0 g
g,g 113) R ECONS TITUTE D (171 MISRE A0 00St FOR OTHER P ATitNT wmONQ REAGtNT Kjf CA LitR ATOR (321 BRoucMT wmONG (ISI MISuNDE RSTOOO (22) Recut 4Tf D STuov R AD#OPM A R M ACluTICAL FOR wRONQ P ATIE NT (141 PLACE O RECON $TITUTE D OR 00$ AGE ORotR PATitNT TO CLINIC t331 SEL,ECTE,D WRONG vlAL IN WRONG 3MsELO p
g g
CART (Niel CONTRituisNO F ACTORS INtli ACTION T AKEN TO PMEVENT RECURRENCE 1806 t'uotNT TECHNOLOGtST 185) REQuisiitON NOT CHECKID suPLEMENT NEW PROCE00RES FOR IC63 R
$ Pt Ry l$lON pp igliestw EMPtovtl isos PATIENT CHART N0" (Cil vEmiFICAfiON OF REcutST (021 FOREIGN LANQuAcg IC2i M ADe0PM AR WACluTIC AL
~
(C7) NO ACTION
($31 PAf ttNT INCOHERENT On ta 71 NEW PROCT 0VRE LAS$ LING AND M ANDLING IC3) VEmisiC ATION os P AfitNT (C8t OTHER UNCONSCIOUS IDE N TIF #CA TION 488) ME Avv WORK LOAD 184) 10 SR ACE LtY NOT CHECKED IC4) REINST AUCY PERSONNEL ICS) R EPRiW AND PE RSONNE L (N161 IFFECT ON PAfif NTS l NONE APPARENT
$tf ASSTR ACT IN17) A8$TR AC7 f(f mer9 EParf 4 r#Wwwpd etterA #detacedf sAsem) f Y rM A
O L4 W
^O?O$
' fle
[9 Nl 0 P
0L e
NUCLE AR RtGULATORY COMMIS$10N U$t
.:N i si IN isi (N20p RE GioN AL LOG IN2tl ACCElllON NUW8ER IN221 Nefi ALS A$
NUWSER 49995 's t 8 l I III IIIIII I III I
' " " No l
l l
AMA4 POR, NPC FORJ 473 U S. NUCLE A3 f.EGULAf 0 AY COMMIS$ TON 14 8 %
Apuro e4 by 098 to CF A e 35 33 3150 0:40 E evni t 3188 DIAGNOSTIC MISADMINISTRATION REPOFIT (Nil UCE Nill N AWE liN2l UCENSE NUWSER Il l-l l l l l l-l l tN 2) Cif Y iN8' ST Af t
- N5i EvtNT cart
.Nel REPOR f cart MONfM QAY vtAR UCNIH OAY TEAR l !
i e
i l
l~
IN1) TYPE OF ui1ADwiNistR AtlON IN8 OoD TMt WisADuiNesTR ATiON iNv0 Lyt AN IN91 NUMBEtt OP P A ritN rg w.eO RgCgag to ISOTOPE OF IO0iNE A His Aousmisf R A7 SON UNOf A TMl3 REPOR f 6011 WRONG 102) DO$ AGE DiF F E RING P tDeOPMA R MACEUTIC A L PROM PRESCRitt0 9Y 50%
l 19901 Y ES l
lfililNO 1031 WRONO PATIENT fosi WRONG Routs (NIO) INT E NDE D IN t0Al INT E Not o LNIil G VEN (061 NUCLEAR df 01 CINE 10010LTR ASOUNo sfuCY weLUCURall ISOTOPE CMEgCA L STUDY WILLICURIES ISOTOPE 1051 NO CUN6C* L PROCEDVRE CMt C
po u '
STUOY y0 STUOFICompee'ED W M CT87UDY s
[k, (10l NW STUOY D
107) N MAY $fv0V di tt OTHER :
int 21 PRECIPf f ATOR 171) REFE RRING PHYSICS AN 176) MOf LAs TECHNOLOGasT (721 WARD NURSE 177) IMAGING TECMrsOLOGIST (7h WARD CLEME (731 CUNiC RECEPflONIST
~
(741 NUCLE AR PMARMACY (79) SCHEDUUNG TECHNOLOGIST NAME OP NvCLEAR PHARMACY l CITY l3 FATS ggog payiggy 180OTHER-(N138 (RROM MOT LAG MtFERRAL A0 Mini 3 TR A flON 01MER liti WISLASELf D A SYRINGE till SILICTED wmONG vial (20) WISUNDER 57000 1301 SE LECTE D WRONG 140) Saec fr WHEN DR awing OO$ AGE REF ERRING PHY$1CI AN $
PATitNT 1121 Mi3LAEELED A vlAL REOyggf Om vl AL sM8 ELD (ISI SE E
UtRATOR
'3 U
'"I 0
'f(0E0 (2H RIOUESTED WRONG pog orggn,N E M PAG (13) RsCONtfiTUTED (173 WISRE AD OO$f 8 UO 4ygggy wmONG REAGENT Klf (18) WisuN0E RsTOOO (22) R EQUESTED 5fuCY (321 BROUGHT w11 TONG CAU9A ATOR R AOiOPM ARM A C EUTICA L FOR wmONG PATIENT 19 41 PLACf D RECONSTITUTEO OR DOSAGE ORotR PATIENf f0 CUNic ve AL IN WI,0NG SMIE LD 1338 stLECTED wmONG 3TRiNGE Frow 00$ AGE i
CART l
Intal CONTRISUTING f ACTORS INi'A ACTION TAKEN TO PREVENT RECURRENCE I
(80l lTUOf Nf f ECHNOLOGest t3SI REOutsiflON NOT >ECKED suPLEMENf 4EW PROCEOURES FOn IC6s uPmO UPE R VISION pp l
(pt) NEW EMPLOYgg 186) PATIENT CMART NOT (Cil vtR F6 CATION OP RIOutsf CHECKl0 IC 21 R A 0iOPMARMACEUTICA L i
1871 FOREIGN LANGUAGg (C7) NO ACfiON 183) P AYlE NT INCOME R ENT OR 184 NEW proct 0URE LA8EUNG AND MANDLING l
UNCONSCsOUS IC38 vtR18lC ATION Oi P AfitNT IOt NiiF sCA TION IC81OTHER El HE AVY WORK LOA D (34* eO GR ACILET NOT CHECK 80 IS9 OfMtR-iCS) REPRlW AND PER$0NNEL IN tel 5F F ECT ON P Afif NTS l NONE APPARENT Sif AS$TR ACT m i n A.. r R AC T ~ ~. ~,,,.A M,
, s.,,,
1 e
i J
V l
I 1
NUCLE AR REGULAYORY COMMISSION USE tNiti IN.its N20t Rtca.ON AL LOG IN2n ACCgss#ON NuveER iN22i iNiti A Ls A
Nuo ER 1999:YES l l l l l l l l l l l l l l l l (I t il NO